Nippon Express Europe GmbH (hereinafter "NX Europe"), a Duesseldorf, Germany-based core company of NIPPON EXPRESS HOLDINGS, INC., is pleased to announce its participation in "transport logistic 2025," ...

Genentech’s short film draws on the experiences of multiple families caring for children with hemophilia A, seeking to ...

Novellia, Inc., the AI health data platform trusted by leading biopharma companies to uncover hidden insights in real-world patient data, today announced the launch of Project EVEREST—a groundbreaking ...

The Swiss pharma has inked several collaborations in this field, suggesting it sees the approach as promising to rid the body ...

Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

Genentech, a member of the Roche Group, has announced that it is voluntarily withdrawing the US indication of Tecentriq (atezolizumab) for the treatment of adult patients with certain types of ...

Shieldworkz, a leading cybersecurity innovator, today announced the expansion of its Cyber-Physical System security offerings. This strategic move addresses the evolving threat landscape, increasing ...

Myasthenia gravis is an autoimmune disorder in which antibodies disrupt the communication between nerves and muscles, ...

The FDA has approved Johnson & Johnson's anti-FcRn antibody, nipocalimab, for the treatment of generalized myasthenia gravis. The drug will be sold under the brand name IMAAVY. This approval ...

© 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...

The 2025 Forum was held May 19-21, 2025, at the Seaside Civic & Convention Center in Seaside, Oregon. Join us next year for the Forum on Rural Population Health, an annual event dedicated to enhancing ...